Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia

Aníbal A. Teherán, Gabriel Camero, Carolina Hernández, Luis Perez-Garcia, Renato Gúzman, Alberto Paniz-Mondolfi, Juan David Ramírez

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

Coronavirus disease 2019 (COVID‐19) pandemic has challenged healthcare systems around the world. Unfortunately, failure has become evident with the collapse of high‐income countries where excellent‐quality and efficient systems—with enough resources and advanced scientific technology to establish strong public health strategies based on mathematical models adjusted to serve COVID‐191—have undergone significant strain.

Currently, there are no effective pharmacological interventions with sufficient scientific evidence to treat COVID‐19. Fueled by the epidemiological and clinical impact of its rapid spread, and the alarming fatality rates of over 10% in some countries, the need for in‐hospital management—especially in intensive care units (ICU)—geared public health attention towards previous pharmacological experiences evaluated in other coronavirus strains.
Translated title of the contributionPosibles efectos negativos del uso gratuito de cloroquina para el manejo de COVID-19 en Colombia
Original languageEnglish (US)
Pages (from-to) 2254-2256
Number of pages2
JournalJournal of Medical Virology
Volume92
Issue number11
DOIs
StateAccepted/In press - May 26 2020

All Science Journal Classification (ASJC) codes

  • Virology
  • Infectious Diseases

Cite this